Literature DB >> 16741884

Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status.

James R Johnson1, Michael A Kuskowski, Megan Menard, Abby Gajewski, Mariona Xercavins, Javier Garau.   

Abstract

BACKGROUND: The food supply is suspected to be a source of fluoroquinolone-resistant Escherichia coli that cause disease in humans, but supporting molecular data are lacking.
METHODS: We performed a molecular-epidemiological comparison, in Barcelona, Spain (1996-1998), of 117 contemporaneous, geographically matched E. coli isolates from humans (35 blood isolates and 33 fecal) or chickens (49 fecal) that were either susceptible (n = 57) or resistant (n = 60) to ciprofloxacin and analyzed them by phylogenetic group, virulence genotype, and O antigens using random amplified polymorphic DNA (RAPD) analysis and pulsed-field gel electrophoresis (PFGE).
RESULTS: When analyzed by phylogenetic distribution, virulence profiles, and O antigens, resistant human isolates were distinct from susceptible human isolates but were largely indistinguishable from chicken isolates, whereas resistant and susceptible chicken isolates were similar. Susceptible human isolates contained more virulence-associated genes and more frequently expressed virulence-associated O antigens than did resistant human or any chicken isolates. Certain resistant human isolates closely resembled chicken isolates by RAPD and PFGE analysis.
CONCLUSIONS: Ciprofloxacin-resistant E. coli may arise de novo in poultry from susceptible progenitors, be transmitted to humans via the food supply, and go on to cause potentially life-threatening infections. If confirmed, these findings would mandate efforts to eliminate this reservoir of drug-resistant pathogens and/or to block their transmission to humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741884     DOI: 10.1086/504921

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents.

Authors:  Michael J Pultz; Michelle M Nerandzic; Usha Stiefel; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

2.  Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.

Authors:  Pauline D Scanlan; Anna M Bischofberger; Alex R Hall
Journal:  FEMS Microbiol Ecol       Date:  2016-10-12       Impact factor: 4.194

3.  Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli, Including Sequence Type 131 (ST131), from Retail Chicken Breasts in the United States in 2013.

Authors:  James R Johnson; Stephen B Porter; Brian Johnston; Paul Thuras; Sarah Clock; Michael Crupain; Urvashi Rangan
Journal:  Appl Environ Microbiol       Date:  2017-03-02       Impact factor: 4.792

4.  Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat.

Authors:  L Jakobsen; P Garneau; G Bruant; J Harel; S S Olsen; L J Porsbo; A M Hammerum; N Frimodt-Møller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-28       Impact factor: 3.267

5.  Molecular analysis of antimicrobial-susceptible and -resistant Escherichia coli from retail meats and human stool and clinical specimens in a rural community setting.

Authors:  Elizabeth Lyon Hannah; James R Johnson; Frederick Angulo; Bassam Haddadin; Jacquelyn Williamson; Matthew H Samore
Journal:  Foodborne Pathog Dis       Date:  2009-04       Impact factor: 3.171

6.  European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.

Authors:  Simone Cagnacci; Laura Gualco; Eugenio Debbia; Gian Carlo Schito; Anna Marchese
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

7.  Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004.

Authors:  James R Johnson; Mark R Sannes; Cynthia Croy; Brian Johnston; Connie Clabots; Michael A Kuskowski; Jeff Bender; Kirk E Smith; Patricia L Winokur; Edward A Belongia
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

8.  Broiler chickens as source of human fluoroquinolone-resistant Escherichia coli, Iceland.

Authors:  Thorunn R Thorsteinsdottir; Gunnsteinn Haraldsson; Vala Fridriksdottir; Karl G Kristinsson; Eggert Gunnarsson
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

9.  Increasing resistance in commensal Escherichia coli, Bolivia and Peru.

Authors:  Alessandro Bartoloni; Lucia Pallecchi; Costanza Fiorelli; Tiziana Di Maggio; Connie Fernandez; Ana Liz Villagran; Antonia Mantella; Filippo Bartalesi; Marianne Strohmeyer; Angela Bechini; Herlan Gamboa; Hugo Rodriguez; Charlotte Kristiansson; Göran Kronvall; Eduardo Gotuzzo; Franco Paradisi; Gian Maria Rossolini
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Food reservoir for Escherichia coli causing urinary tract infections.

Authors:  Caroline Vincent; Patrick Boerlin; Danielle Daignault; Charles M Dozois; Lucie Dutil; Chrissi Galanakis; Richard J Reid-Smith; Pierre Paul Tellier; Patricia A Tellis; Kim Ziebell; Amee R Manges
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.